Find out what’s happening at Pivot Park. Stay informed on the latest collaborations, scientific breakthroughs and developments in drug discovery and life sciences. Explore how innovators at the park are shaping the future of health, technology and entrepreneurship.
Dennis Löwik: New lector Drug Discovery at Pivot Park
Dennis Löwik is the new Drug Discovery lecturer at Pivot Park, aiming to boost research with AI and foster industry collaborations. He aims to expand the lectureship in terms of people and research in the coming years.
Pivot park proud sponsor of the PhD Competition at FIGON Dutch Medicine Days
This past Wednesday and Thursday, the Figon Dutch Medicine Days took place, where we were proud to sponsor the PhD Award. This initiative provides talented PhD candidates from different regions with the opportunity to present their innovative research.
Minister of Health, Pia Dijkstra, visited Pivot Park
On 15 May 2024, we had the pleasure of a visit from our Minister of Health, Pia Dijkstra. We provided insights into our operations, and afterwards, we discussed strategies for tackling and preventing medicine shortages in the future.
Unveiling Pivot Park’s new Business Hub
Discover Pivot Park’s new Business Hub, uniting 14 companies in the campus center. Empowering biopharmaceutical startups and scale-ups for collaborative innovation in pioneering R&D. Join us at the forefront of advancing medicine.
Introducing the Pedro Hermkens Stipend: Empowering professional growth at Pivot Park
At Pivot Park, we recognize the importance of investing in the ongoing development of our community members. The Pedro Hermkens Stipend offers our community a maximum award of 1,000 euros, providing vital support for their career endeavours.
Following almost two years of construction, the Curie building at Pivot Park is nearly ready to welcome its first tenants. This compact 9-storey building, offering plenty of light and easy adaptation to tenants’ needs, is designed based on collaboration, with a central meeting hub and office spaces, customised laboratories, and communal facilities.
Press release: Pivot Park grows by over 25% with the completion of the Grizzly project
Today, contractor Dura Vermeer Bouw Zuid completes the Grizzly project after nearly 2 years of construction, delivering it to Pivot Park. The 9-story building, named after Nobel laureate Marie Curie, will house offices, laboratories, and shared facilities. With the completion of this sustainable building, Pivot Park adds 11,000 square meters to its successful campus, marking an expansion of over 25 percent.
Pharma cluster wraps up 100-Year celebration with successful Pharma Future Run
Pivot Park hosted the Pharma Future Walk last Sunday, concluding a year-long celebration of Oss’s 100-year pharmaceutical history. The starting and finishing lines were right here at Pivot Park, with a unique route through Oss’s pharmaceutical companies.
Leaders in Life Sciences – #22 Nettie Buitelaar
In the Leaders of Life Sciences Podcast, André van de Sande talks to leaders of now and soon in the life sciences sector. We believe that there needs to be more spoken by people in the sector about themselves but also about their work. That starts with the leaders of today who are questioned about their careers and motivations. These are leaders working in the broadest corners of the industry, but they all have one thing in common: our guests all have a mission to contribute to improving health worldwide. In episode 22, our guest is Nettie Buitelaar, CEO of Biotech Booster.
Leaders in Life Sciences – #21 Paul Peter Tak
In the Leaders of Life Sciences Podcast, André van de Sande talks to leaders of now and soon in the life sciences sector. We believe that there needs to be more spoken by people in the sector about themselves but also about their work. That starts with the leaders of today who are questioned about their careers and motivations. These are leaders working in the broadest corners of the industry, but they all have one thing in common: our guests all have a mission to contribute to improving health worldwide. In episode 21, our guest is Paul Peter Tak, CEO of Candel Therapeutics.
Pivot Park opens its doors with the unveiling of the Walk of Fame
Always wanted to know what goes on behind closed doors at Pivot Park? From today on, you get the opportunity to learn more about the biopharmaceutical park and its residents. Follow the Walk of Fame at Pivot Park: a route of photos, videos, and audio which tells you in an interactive way the stories the companies at Pivot Park have to tell you.
Pivot Park sponsors iGEM TU Eindhoven team to address inflammatory bowel disease
The iGEM TU Eindhoven team, renowned for innovation, secures sponsorship from Pivot Park for their pioneering project targeting inflammatory bowel disease (IBD). Following their victory in the previous #IGEM Grand Jamboree, the 2023 team takes on the challenge of IBD, impacting around 4.9 million globally. By designing a modular platform of engineered probiotics, the team aims to revolutionize IBD treatment and potentially address various bowel diseases, offering a safer and more effective solution than current systemic treatments.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.